Skip to main content

Table 2 (abstract A35). Analysis of OraQuick ADVANCE saliva cross-reactivity with blood tests

From: Abstracts from the 4th Annual Student Medical Summit

HIV-1 Diagnostic Test

Participants Testing Reactive

n (%)

p value vs OraQuick ADVANCE

OraQuick ADVANCE

0 of 120 (0%)

----

BioRad GS

65 of 120 (54%)

< 0.0001

Abbott Architect

76 of 120 (63%)

< 0.0001

Alere Determine

58 of 120 (48%)

< 0.0001

Abbott Prism1

41 of 43 (95%)

< 0.0001

  1. 1 Abbott Prism was only used if samples tested negative on all three of the fourth-generation antigen/antibody tests (n=41)